The Cancer Genetics and Genomics Laboratory (CGL) at BC Cancer will be commencing panel-based next generation sequencing (NGS) or “Focus Panel” testing starting May 2021. The AmpliSeq for Illumina Focus Panel enables rapid and accurate assessment of genomic variants in 52 genes with known clinical relevance in solid tumors. Additional details of the test and indications that qualify for this testing can be found in the memo below.